Where does Intellikine LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Intellikine LLC ranks #11,680 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Intellikine LLC hold?

Intellikine LLC holds 26 US utility patents granted between 2015 and 2022, spanning 11 technology areas.

What is Intellikine LLC's Innovation Score?

Intellikine LLC has an Innovation Score of 38.5 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Intellikine LLC focus on?

Intellikine LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 25 patents, ranking #782 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Intellikine LLC's patent grant rate increasing or decreasing?

Intellikine LLC's recent grant velocity is -96% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Intellikine LLC's patents?

Intellikine LLC's patents average 14.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Intellikine LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Intellikine LLC

USPTO PatentsView assignee record - 26 granted patents across 11 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Intellikine ranks #11,680 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 11 technology areas.

#11,680
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.5/100): 14.5
avg claims per patent: -96%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11680 · US Corporation #11,680 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,680/49,997
PHOTO-FINISH Imation
CPC-FOCUS A61P · 11 areas
INNOV-THIN 38.5/100
CLAIMS-RICH 14.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -96% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Imation Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Intellikine’s 38.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (30%) Velocity 6.7 pts (17%) Breadth 11.7 pts (30%) Claim depth 8.7 pts (23%)

Qualcomm Incorporated · highest

85
Blue Danube Systems · near

39
Intellikine · this assignee

39
Maui Imaging · near

39
Neuwave Medical · near

39
Tensorcom · near

39
3D Lighting… · lowest

7

What this shows Intellikine's Innovation Score is 38.5/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Intellikine?

Each dot is one of Intellikine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intellikine’s own 14.5 claims/patent is at or below the 14.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Intellikine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Intellikine's grants concentrate

Intellikine LLC is a focused PatentsView assignee: 11 CPC subclasses with 96.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2019. By volume, Intellikine sits between Innovator Energy LLC. and Interscope, Inc..

Intellikine's three-year grant acceleration

Intellikine LLC shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Innovator Energy

26
Institut National…

26
Imation

26
Integra Bioscienc…

26
Inter-university…

26
Interactive Intel…

26
International Sem…

26
Interscope

26
Intellikine ◀

26

What this shows Intellikine holds 26 patents at rank #11,680, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Intellikine

By rank, the assignees closest to #11,680 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Intellikine's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Intellikine, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Intellikine ranks #782 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Blue Danube Systems, Inc. 39 Tensorcom, Inc. 39 Neuwave Medical, Inc. 39 Maui Imaging, Inc. 39

Intellikine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Intellikine LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	30.8%
2016	8	30.8%
2017	8	30.8%
2019	1	3.8%
2022	1	3.8%

Which technologies does Intellikine LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 25

C07D - Heterocyclic Compounds 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

Y02A - Technologies FOR Adaptation TO Climate Change 10

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Intellikine LLC's patent record in context - here's where to go next.

Intellikine LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 96.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #11,680 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Intellikine LLC against Innovator Energy LLC., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.